Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AARTI DRUGS vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AARTI DRUGS ZYDUS LIFESCIENCES AARTI DRUGS/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 22.4 34.6 64.8% View Chart
P/BV x 3.4 5.8 58.2% View Chart
Dividend Yield % 0.2 0.6 38.4%  

Financials

 AARTI DRUGS   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    AARTI DRUGS
Mar-23
ZYDUS LIFESCIENCES
Mar-23
AARTI DRUGS/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs532495 107.4%   
Low Rs311319 97.3%   
Sales per share (Unadj.) Rs293.3170.3 172.2%  
Earnings per share (Unadj.) Rs18.019.8 90.8%  
Cash flow per share (Unadj.) Rs23.426.9 86.9%  
Dividends per share (Unadj.) Rs1.006.00 16.7%  
Avg Dividend yield %0.21.5 16.1%  
Book value per share (Unadj.) Rs128.8173.0 74.4%  
Shares outstanding (eoy) m92.601,012.20 9.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.42.4 60.1%   
Avg P/E ratio x23.420.6 113.9%  
P/CF ratio (eoy) x18.015.1 119.0%  
Price / Book Value ratio x3.32.4 139.0%  
Dividend payout %5.630.3 18.3%   
Avg Mkt Cap Rs m39,003412,144 9.5%   
No. of employees `000NANA-   
Total wages/salary Rs m80424,564 3.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,161172,374 15.8%  
Other income Rs m224,746 0.5%   
Total revenues Rs m27,182177,120 15.3%   
Gross profit Rs m3,09529,677 10.4%  
Depreciation Rs m5037,227 7.0%   
Interest Rs m3711,299 28.6%   
Profit before tax Rs m2,24225,897 8.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5785,878 9.8%   
Profit after tax Rs m1,66420,019 8.3%  
Gross profit margin %11.417.2 66.2%  
Effective tax rate %25.822.7 113.6%   
Net profit margin %6.111.6 52.7%  
BALANCE SHEET DATA
Current assets Rs m14,923100,082 14.9%   
Current liabilities Rs m9,33055,267 16.9%   
Net working cap to sales %20.626.0 79.2%  
Current ratio x1.61.8 88.3%  
Inventory Days Days650 11.3%  
Debtors Days Days1,16294 1,242.7%  
Net fixed assets Rs m9,290144,776 6.4%   
Share capital Rs m9261,012 91.5%   
"Free" reserves Rs m10,998174,146 6.3%   
Net worth Rs m11,924175,158 6.8%   
Long term debt Rs m2,0470-   
Total assets Rs m24,214244,940 9.9%  
Interest coverage x7.020.9 33.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.10.7 159.4%   
Return on assets %8.48.7 96.6%  
Return on equity %14.011.4 122.1%  
Return on capital %18.715.5 120.5%  
Exports to sales %31.439.2 80.2%   
Imports to sales %33.411.9 280.6%   
Exports (fob) Rs m8,53667,577 12.6%   
Imports (cif) Rs m9,08220,544 44.2%   
Fx inflow Rs m8,53667,577 12.6%   
Fx outflow Rs m9,35220,544 45.5%   
Net fx Rs m-81647,033 -1.7%   
CASH FLOW
From Operations Rs m1,34226,888 5.0%  
From Investments Rs m-1,64011,712 -14.0%  
From Financial Activity Rs m165-44,004 -0.4%  
Net Cashflow Rs m-132-5,338 2.5%  

Share Holding

Indian Promoters % 57.5 75.0 76.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.4 18.0 40.8%  
FIIs % 2.1 5.0 42.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.5 25.0 170.0%  
Shareholders   170,414 306,495 55.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AARTI DRUGS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on AARTI DRUGS vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AARTI DRUGS vs Cadila Healthcare Share Price Performance

Period AARTI DRUGS Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.26% 1.51% 1.42%
1-Month -12.01% 8.78% -0.51%
1-Year 27.25% 109.48% 62.21%
3-Year CAGR -14.68% 32.71% 18.25%
5-Year CAGR 22.19% 24.76% 19.84%

* Compound Annual Growth Rate

Here are more details on the AARTI DRUGS share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of AARTI DRUGS hold a 57.5% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AARTI DRUGS and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, AARTI DRUGS paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 5.6%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of AARTI DRUGS, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.